ISOLATED KIDNEY TRANSPLANTATION UNDER LUMASIRAN THERAPY IN PRIMARY HYPEROXALURIA TYPE 1 (PH1): A REPORT ON 3 CASES

被引：0
|
作者：
Sellier-leclerc, Anne-Laure [1 ]
Levi, Charlene [1 ]
Acquaviva-bourdain, Cecile [1 ]
Clave, Stephanie [2 ]
Bacchetta, Justine [1 ]
机构：
[1] Hosp Civils Lyon, Lyon, France
[2] Assitance Publ Hop Marseille, Marseille, France
来源：
PEDIATRIC NEPHROLOGY | 2022年 / 37卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
OP-42
引用
收藏
页码：2819 / 2819
页数：1
相关论文
共 50 条
  • [21] SAFETY AND EFFICACY STUDY OF LUMASIRAN, AN INVESTIGATIONAL RNA INTERFERENCE (RNAI) THERAPEUTIC, IN ADULT AND PEDIATRIC PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 (PH1)
    Frishberg, Yaacov
    Deschenes, Georges
    Cochat, Pierre
    Magen, Daniella
    Groothoff, Jaap
    Hulton, Sally A.
    Harambat, Jerome
    Hoff, William Vant
    Hoppe, Bernd
    Lieske, John C.
    McGregor, Tracy L.
    Haslett, Patrick
    Talamudupula, Sandeep
    Erbe, David V.
    Milliner, Dawn S.
    JOURNAL OF UROLOGY, 2019, 201 (04): : E174 - E174
  • [22] Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
    Shah, Viral N.
    Pyle, Laura
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (20):
  • [23] Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
    Garrelfs, Sander F.
    Frishberg, Yaacov
    Hulton, Sally A.
    Koren, Michael J.
    O'Riordan, William D.
    Cochat, Pierre
    Deschenes, Georges
    Shasha-Lavsky, Hadas
    Saland, Jeffrey M.
    van't Hoff, William G.
    Fuster, Daniel G.
    Magen, Daniella
    Moochhala, Shabbir H.
    Schalk, Gesa
    Simkova, Eva
    Groothoff, Jaap W.
    Sas, David J.
    Meliambro, Kristin A.
    Lu, Jiandong
    Sweetser, Marianne T.
    Garg, Pushkal P.
    Vaishnaw, Akshay K.
    Gansner, John M.
    McGregor, Tracy L.
    Lieske, John C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13): : 1216 - 1226
  • [24] DIGESTIVE MANIFESTATIONS OF PRIMARY HYPEROXALURIA TYPE1(PH1) IN CHILDREN
    Gazzeh, Souhir
    Nouir, Selsabil
    Mabrouk, Sameh
    Tfifha, Meniar
    Ajmi, Houda
    Majdoub, Fadwa
    Jaleleddine, Chemli
    Zouari, Noura
    Saoussen, Abroug
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3468 - 3469
  • [25] Correction: Lumasiran: A Review in Primary Hyperoxaluria Type 1
    Connie Kang
    Drugs, 2024, 84 (3) : 371 - 371
  • [26] Primary Hyperoxaluria Type 1 (PH1) Presenting With End-Stage Kidney Disease and Cutaneous Manifestations in Adulthood: A Case Report
    Poyah, Penelope
    Bergman, Joel
    Geldenhuys, Laurette
    Wright, Glenda
    Walsh, Noreen M.
    Hull, Peter
    Roche, Kristina
    West, Michael L.
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2021, 8
  • [27] New Gene Therapy Approach for the Treatment of Primary Hyperoxaluria Type 1 (PH1) Patients. Proof of Concept in a Mouse Model of PH1
    Molinos-Vicente, Andrea
    Garcia-Torralba, Aida
    Nieto-Romero, Virginia
    Rodriguez-Diaz, Saray
    Cantore, Alessio
    Roberto Rodriguez-Madoz, Juan
    Salido, Eduardo
    Carlos Segovia, Jose
    Garcia-Bravo, Maria
    MOLECULAR THERAPY, 2021, 29 (04) : 246 - 246
  • [28] EUROPEAN PH1 TRANSPLANT REGISTRY REPORT ON THE RESULTS OF COMBINED LIVER-KIDNEY TRANSPLANTATION FOR PRIMARY HYPEROXALURIA 1984 TO 1992
    JAMIESON, NV
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 1234 - 1236
  • [29] GENETIC-ANALYSIS OF PATIENTS WITH PRIMARY HYPEROXALURIA TYPE-1 (PH1)
    FRISHBERG, Y
    REINER, O
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 621 - 621
  • [30] Re: Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
    不详
    JOURNAL OF UROLOGY, 2021, 206 (05): : 1322 - 1322
12345